Dr. Thomas M. Rinderknecht

Thomas M. Rinderknecht was born in 1954 and is a Swiss citizen. He is an attorney-at-law and senior partner at Badertscher Rechtsanwälte AG, Zurich and Zug. He has served on the Boards of Directors of several biotech, pharma and medtech companies, including SkyePharma Plc, UK; Antares Pharma Inc., USA; Speedel Holding AG, Switzerland; GlycArt Biotechnology AG, Switzerland, and Ganymed Pharmaceuticals AG, Germany. He currently serves as Chairman of Canyon Pharmaceuticals AG, and Vice-Chairman of APR Applied Pharma Research SA, both in Switzerland. Dr. Rinderknecht holds a PhD in law from the University of Zurich and is admitted to the Bar in Zurich.